biotech / news / / Firstpost
Danish healthcare giant Novo Nordisk has confirmed a major collaboration aimed at redefining how chronic diseases are treated.
Novo Nordisk has formed a strategic partnership with OpenAI to transform drug discovery.
KEY POINTS
- The collaboration aims to use AI algorithms to identify biological targets faster than traditional methods.
- Novo Nordisk will leverage OpenAI's data processing to streamline clinical trials and predict molecule interactions.
- No financial details of the Novo Nordisk and OpenAI partnership have been disclosed.
COMPANIES
Summarized by Newsio from Firstpost. How we summarize →